News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,829 Results
Type
Article (68196)
Company Profile (147)
Press Release (620485)
Multimedia
Podcasts (112)
Webinars (16)
Section
Business (194032)
Career Advice (2262)
Deals (31939)
Drug Delivery (113)
Drug Development (76246)
Employer Resources (144)
FDA (16216)
Job Trends (14749)
News (326796)
Policy (31999)
Tag
Academia (2931)
Academic (2)
Accelerated approval (11)
Adcomms (24)
Allergies (105)
Alliances (50898)
ALS (115)
Alzheimer's disease (1534)
Antibody-drug conjugate (ADC) (168)
Approvals (16234)
Artificial intelligence (361)
Autoimmune disease (31)
Automation (18)
Bankruptcy (288)
Best Places to Work (11221)
BIOSECURE Act (21)
Biosimilars (119)
Biotechnology (94)
Bladder cancer (93)
Brain cancer (37)
Breast cancer (381)
Cancer (2974)
Cardiovascular disease (228)
Career advice (1915)
Career pathing (28)
CAR-T (191)
CDC (39)
Cell therapy (525)
Cervical cancer (25)
Clinical research (62174)
Collaboration (1104)
Compensation (358)
Complete response letters (24)
COVID-19 (2719)
CRISPR (62)
C-suite (351)
Cystic fibrosis (110)
Data (3081)
Decentralized trials (2)
Denatured (40)
Depression (76)
Diabetes (344)
Diagnostics (6223)
Digital health (25)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (170)
Drug pricing (138)
Drug shortages (31)
Duchenne muscular dystrophy (143)
Earnings (78117)
Editorial (49)
Employer branding (20)
Employer resources (128)
Events (98437)
Executive appointments (842)
FDA (17973)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (957)
Gene editing (127)
Generative AI (36)
Gene therapy (402)
GLP-1 (854)
Government (4710)
Grass and pollen (6)
Guidances (216)
Healthcare (18621)
HIV (43)
Huntington's disease (23)
IgA nephropathy (42)
Immunology and inflammation (154)
Immuno-oncology (12)
Indications (41)
Infectious disease (2900)
Inflammatory bowel disease (145)
Inflation Reduction Act (10)
Influenza (65)
Intellectual property (119)
Interviews (405)
IPO (14001)
IRA (52)
Job creations (3901)
Job search strategy (1622)
Kidney cancer (12)
Labor market (47)
Layoffs (494)
Leadership (20)
Legal (7711)
Liver cancer (82)
Longevity (12)
Lung cancer (417)
Lymphoma (213)
Machine learning (12)
Management (48)
Manufacturing (424)
MASH (96)
Medical device (14224)
Medtech (14229)
Mergers & acquisitions (18623)
Metabolic disorders (881)
Multiple sclerosis (99)
NASH (18)
Neurodegenerative disease (138)
Neuropsychiatric disorders (39)
Neuroscience (2253)
NextGen: Class of 2025 (6475)
Non-profit (4797)
Now hiring (38)
Obesity (445)
Opinion (250)
Ovarian cancer (106)
Pain (117)
Pancreatic cancer (118)
Parkinson's disease (184)
Partnered (24)
Patents (299)
Patient recruitment (181)
Peanut (51)
People (55593)
Pharmaceutical (36)
Pharmacy benefit managers (21)
Phase I (19029)
Phase II (26999)
Phase III (20875)
Pipeline (1715)
Policy (229)
Postmarket research (2814)
Preclinical (8786)
Press Release (70)
Prostate cancer (154)
Psychedelics (43)
Radiopharmaceuticals (261)
Rare diseases (469)
Real estate (5910)
Recruiting (58)
Regulatory (22213)
Reports (38)
Research institute (2618)
Resumes & cover letters (343)
Rett syndrome (8)
RNA editing (11)
RSV (58)
Schizophrenia (100)
Series A (158)
Series B (104)
Service/supplier (14)
Sickle cell disease (64)
Special edition (21)
Spinal muscular atrophy (149)
Sponsored (32)
Startups (3559)
State (1)
Stomach cancer (15)
Supply chain (76)
Tariffs (70)
The Weekly (70)
Vaccines (867)
Venture capital (56)
Weight loss (300)
Women's health (39)
Worklife (16)
Date
Today (92)
Last 7 days (508)
Last 30 days (1731)
Last 365 days (29546)
2025 (17186)
2024 (33172)
2023 (37666)
2022 (48659)
2021 (52859)
2020 (51728)
2019 (45771)
2018 (34929)
2017 (32178)
2016 (32058)
2015 (37299)
2014 (30922)
2013 (27689)
2012 (28510)
2011 (28569)
2010 (27292)
Location
Africa (934)
Alabama (67)
Alaska (6)
Arizona (205)
Arkansas (11)
Asia (41731)
Australia (7175)
California (6700)
Canada (2244)
China (699)
Colorado (306)
Connecticut (327)
Delaware (199)
Europe (94438)
Florida (1089)
Georgia (251)
Hawaii (1)
Idaho (58)
Illinois (644)
India (30)
Indiana (366)
Iowa (16)
Japan (244)
Kansas (105)
Kentucky (32)
Louisiana (15)
Maine (42)
Maryland (1010)
Massachusetts (4976)
Michigan (258)
Minnesota (445)
Mississippi (4)
Missouri (84)
Montana (31)
Nebraska (23)
Nevada (72)
New Hampshire (74)
New Jersey (2062)
New Mexico (29)
New York (2019)
North Carolina (1098)
North Dakota (10)
Northern California (2940)
Ohio (234)
Oklahoma (16)
Oregon (32)
Pennsylvania (1501)
Puerto Rico (12)
Rhode Island (37)
South America (1254)
South Carolina (35)
Southern California (2541)
Tennessee (123)
Texas (1070)
United States (26018)
Utah (220)
Virginia (186)
Washington D.C. (75)
Washington State (609)
West Virginia (4)
Wisconsin (73)
688,829 Results for "bill and melinda gates medical research institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dr. Patrice Matchaba Appointed as Chief Executive Officer of the Bill & Melinda Gates Medical Research Institute
The Bill & Melinda Gates Medical Research Institute announced the appointment of Patrice Matchaba, MD, as Chief Executive Officer, starting June 10, 2024.
May 28, 2024
·
3 min read
BioCapital
Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research
Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has signed a three-year agreement with the Bill & Melinda Gates Medical Research Institute to provide its adjuvant for use in preclinical vaccine research.
June 5, 2023
·
4 min read
Biotech Beach
Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound
Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute, announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment.
February 15, 2023
·
4 min read
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
The collaboration focuses on ‘molecular gates,’ a class of molecules that the startup company Gate Bioscience says can stop pathogenic proteins from leaving the cell.
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
October 30, 2024
·
3 min read
Pharm Country
Merck and the Bill & Melinda Gates Medical Research Institute Announce Licensing Agreement for Novel Tuberculosis Antibiotic Candidates
Merck, known as MSD outside of the United States and Canada, and the Bill & Melinda Gates Medical Research Institute announced a licensing agreement for two preclinical antibacterial candidates for evaluation as potential components of combination regimens for the treatment of tuberculosis.
October 18, 2022
·
6 min read
Drug pricing
Senate Republicans Drop Orphan Drug Exemptions From ‘One Big Beautiful Bill’
The new version of the bill will still need to go through the entire House and Senate.
June 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Immorna Receives Grant from Bill & Melinda Gates Foundation to Support Its mRNA RSV Vaccine Clinical Development
August 26, 2024
·
4 min read
Government
Changes to IRA Pill Penalty Conspicuously Absent as Congress Narrowly Passes Trump’s Tax Bill
The “One Big Beautiful Bill Act” includes negotiation exemptions for orphan drugs approved to treat more than one rare disease and has implications for PBMs. Also on Thursday, the White House released its MAHA report with a mission to “make our children healthy again.”
May 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease.
June 11, 2025
·
3 min read
1 of 68,883
Next
